TrialThe New England journal of medicine2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Thierry Conroy et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1,511 papers cite itlatest 60 shown
this paperpooled ittrialcites it